Study of Cell Phone SMS Messages for Prevention of Maternal to Child Transmission of HIV

NCT ID: NCT01157442

Last Updated: 2011-03-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

856 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-07-31

Study Completion Date

2012-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Optimal development of sustainable health systems must use locally relevant infrastructure. Mobile phone technology, driven primarily by local market forces rather than foreign assistance, is spreading rapidly through African communities to improve people's personal and business communications. Here, the investigators propose using a structured mobile phone communications system for prevention of mother to child transmission of HIV (PMTCT). The system is designed to improve antenatal linkage to care, provide reminders to take PMTCT medications, and improve post-natal support and follow-up, even when mothers deliver at home. In addition to benefits in PMTCT related outcomes, this model allows evaluation of the intervention in a public health setting with the ultimate goal of advancing regional health systems development. The overall goal of of the study is to assess if mobile phones and SMS text messages can be used to help improve prevention of maternal to child transmission (PMTCT) of HIV services by strengthening health systems.

Specific objectives are:

1\. To determine if mobile phone SMS text messages can demonstrate an improvement in compliance with a known intervention ( use of nevirapine) for PMTCT, demonstrated by:

1a) improved antenatal care attendance (greater than 4 visits)

1b) increased usage of nevirapine in labour (from 60% to at least 70%)

1c) earlier identification and treatment of HIV positive infants

1d) increased postpartum care for HIV positive mothers

1e) acceptability of cell phone SMS text messages transmission of information among HIV positive women

2\. To demonstrate that mobile phone technology can be used as an effective tool to strengthen PMTCT health information systems at the facility level by: 2a) determining factors that constrain or promote the use of cell phone technology to strengthen PMTCT health information systems from the perspective of patients, health care providers and policy makers 2b) determining how cell phones can be used as a tool to generate equity statistics for PMTCT programs and formulate equity orientated PMTCT policies 2c) determine if early involvement of policy makers in the study improves knowledge translation

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

HIV Infections

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

cell phone sms messages

The experimental arm will receive the cell phone SMS text messaging intervention.

Group Type EXPERIMENTAL

cell phone sms text messaging

Intervention Type BEHAVIORAL

At enrollment a study nurse will send the intervention group a weekly SMS message reminding them to attend antenatal care. Starting at 36 weeks gestational age, an automated bulk SMS management system, will send the intervention group 3 SMS text messages (using non descript slogans) each week by proxy reminding them to take their nevirapine in labor. From time of delivery to 6 weeks postpartum the women will aslo receive 3 SMS messages per week reminding them to attend their 6 week checkup and 6 week infant visit.Upon receiving these messages women in the intervention group can text back if they have any concerns or questions. These women would then receive phone calls from the study nurse triaged according to the women's needs.

Control

The control group will receive the standard of care but no SMS text messages.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

cell phone sms text messaging

At enrollment a study nurse will send the intervention group a weekly SMS message reminding them to attend antenatal care. Starting at 36 weeks gestational age, an automated bulk SMS management system, will send the intervention group 3 SMS text messages (using non descript slogans) each week by proxy reminding them to take their nevirapine in labor. From time of delivery to 6 weeks postpartum the women will aslo receive 3 SMS messages per week reminding them to attend their 6 week checkup and 6 week infant visit.Upon receiving these messages women in the intervention group can text back if they have any concerns or questions. These women would then receive phone calls from the study nurse triaged according to the women's needs.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Women will be eligible to participate if they:

* are pregnant with a singleton pregnancy,
* attend care at Pumwani Maternity Hospital,
* are HIV positive,
* have never had a preterm birth (before 37 weeks),
* are planning to reside in Nairobi for at least 6 months post delivery,
* live within 15 km of PMH,
* have basic literacy skills in Kiswahili or English,
* are willing to be contacted for follow up and have their own cell phone or regular access to their partners' cell phone (partners must be aware of their HIV status).

Exclusion Criteria

* Women who are pregnant and attend care at Pumwani Maternity Hospital who are not HIV positive,
* Women who have had a preterm birth,
* Women who are not planning to reside in Nairobi for at least 6 months post delivery,
* Women who do not live within 15 km of PMH,
* Women who do not have basic literacy skills in English or Kiswahili
* Women who are not willing to be contacted for follow up,
* Women who do not have their own cell phone or regular access to their partner's cell phone and
* Women whose partner's are not aware of their HIV status.
Minimum Eligible Age

18 Years

Maximum Eligible Age

49 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Nairobi

OTHER

Sponsor Role collaborator

Canadian International Development Agency

OTHER_GOV

Sponsor Role collaborator

University of Manitoba

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

University of Manitoba and UNiversity of Nairobi

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Joshua Kimani, MD

Role: PRINCIPAL_INVESTIGATOR

University of Manitoba and University of Nairobi

Peter Cherutich, MD

Role: PRINCIPAL_INVESTIGATOR

Ministry of Health, NASCOP Kenya

Mary Gichuihi, Masters

Role: STUDY_DIRECTOR

University of Nairobi

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Pumwani Maternity Hospital

Nairobi, , Kenya

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Kenya

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Joshua Kimani, MD

Role: CONTACT

Lisa S Avery, MD

Role: CONTACT

1-204 272 3150

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Mary Gichuhi

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

H2009:315

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

mHealth and HIV Self-testing
NCT03569462 COMPLETED NA